详情页 - 首都医科大学宣武医院知识库

当前位置：首页 > 详情页

Tranexamic Acid with Intensive Blood Pressure Management in Ultra-Early Intracerebral Hemorrhage

1| 认领 | 链接全文 |

文献详情

编号/登记号：

注册时间：

研究开始时间：

研究结束时间：

项目类型：

本院角色：

多中心研究：

招募状态：

试验分期：

研究疾病/适应症：

研究类型：

研究负责人：

研究单位： [1]Xuanwu Hospital, Capital Medical University,Beijing,Beijing,China,100053 [2]Beijing Municipal Health Commission [3]Beijing Luhe Hospital, Capital Medical University [4]Suzhou First People's Hospital [5]Linyi People's Hospital [6]Peking University Care Luzhong Hospital [7]Wuzhou Red Cross Hospital [8]Yantai Penglai Traditional Chinese Medicine Hospital [9]The First Affiliated Hospital of Hebei North University [10]Jiaozuo Tumor Hospital [11]Hunan Provincial People's Hospital [12]The People's Hospital of Liaoning Province [13]The First People's Hospital of Qujing, Yunnan Province [14]Huizhou Third People's Hospital, Guangzhou Medical University [15]Nanyang Nanshi Hospital, Henan University [16]Xing'anmeng People's Hospital [17]Beijing Aerospace Center Hospital

关键词： Intracranial Hemorrhage Tranexamic acid Intensive blood pressure lowering Haemostatic therapy

研究目的：

This is a prospective, multicenter, randomized, quadruple-blind, placebo-controlled study. This study aims to estimate the safety and efficacy of intravenous tranexamic acid (TXA) combined with intensive blood pressure lowering in ultra-early spontaneous intracerebral hemorrhage (ICH).